Heartbeam (BEAT) vs DarioHealth (DRIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
DarioHealth (DRIO) has outperformed Heartbeam (BEAT) over the past year, losing 66.8% versus a loss of 72.9%. DarioHealth is the larger company by market cap ($53.2 million vs $27.5 million), about 1.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BEAT | DRIO |
|---|---|---|
| Share price | $0.4887 | $5.43 |
| Market cap | $27.54M | $53.21M |
| 1-day change | -10.00% | -10.69% |
| YTD return | -79.64% | -52.28% |
| 1-year return | -72.85% | -66.83% |
| 5-year return | — | -98.32% |
| EPS (TTM) | $-0.50 | $-2.28 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.00 | $16.50 |
| 52-week low | $0.355 | $5.43 |
| Distance from 52-week high | -87.78% | -67.09% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +616.19% | +150.46% |
| Average volume | 7.37M | 25.00K |
| Shares outstanding | 56.35M | 9.80M |
| Employees | 16 | 160 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Heartbeam
BEAT stock →HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility.
Health Care · Medical/Dental Instruments · 16 employees
About DarioHealth
DRIO stock →DarioHealth Corp. operates as a digital health company in the United States and internationally.
Health Care · Medical/Dental Instruments · 160 employees
BEAT vs DRIO FAQ
Which is bigger, Heartbeam or DarioHealth?
DarioHealth (DRIO) is larger, with a market capitalization of $53.21M compared with $27.54M for Heartbeam (BEAT).
Which stock has performed better over the past year, BEAT or DRIO?
DRIO returned -66.83% over the past 12 months, compared with -72.85% for BEAT (price return, excluding dividends). Past performance does not predict future results.
Are Heartbeam and DarioHealth in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.